Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 461-468

  Mattsson Hultén, Lillemor ^a   Lindmark, Helena ^a   Diczfalusy, Ulf ^b   Björkhem, Ingemar ^b   Ottosson, Malin ^a   Liu, Yani ^a   Bondjers, Göran ^a   Wiklund, Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Cell isolation; Foam cells; Lipid oxidation; RT PCR

Indexed keywords

25 HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; CHOLESTEROL; LIPOPROTEIN LIPASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CELL ISOLATION; DOWN REGULATION; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE FUNCTION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ARTERIOSCLEROSIS; CELLS, CULTURED; CHOLESTEROL; DOWN-REGULATION; FOAM CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYCHOLESTEROLS; LIPOPROTEIN LIPASE; MACROPHAGES; MONOCYTES; RABBITS; RNA, MESSENGER;

EID: 0030060474     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci118436     Document Type: Article

References (53)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C Khoo, and J. L Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med 14 915-924.
2. Brown, M. S , and J. L Goldstein. 1983. Lipoprotein metabolism in the macrophage, implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 52.223-261.
3. Zhang, H., H J. K. Basra, and U. P. Steinbrecher. 1990. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J Lipid Res. 31:361-1369.
4. Jialal, I., D. A. Freeman, and S M. Grundy. 1991. Varying susceptibility of different low density lipoproteins to oxidative modification. Arterioscler. Thromb 11:482-488.
5. Brown, M. S., and J. L. Goldstein. 1975. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts Cell. 6:307-316.
6. Brown, M. S , S. E. Dana, and J. L. Goldstein. 1975. Cholesterol ester formation in cultured human fibroblasts: stimulation by oxygenated sterols. J. Biol. Chem. 250:4025-4027.
7. Morin, R. J , and S. Peng. 1989 Effects of cholesterol oxidation derivatives on cholesterol esterifying and cholesterol ester hydrolytic enzyme activity of cultured rabbit aortic smooth muscle cells. Lipids. 24:217-220.
8. Hu, B., S. Peng, D. Brubaker, and R J. Morin. 1990. Influence of cholesterol oxides and antioxidants on prostacyclin production by cultured endothelial cells. FASEB J. 4:A267, Abstr. No. 3734.
9. Pettersen, K. S , K. M. Boberg, A. Stabursvik, and H. Prydz. 1991. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells Arterioscler. Thromb 11:423-428
10. Sevanian, A , J Berliner, and H Peterson. 1991. Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells. J. Lipid Res 32:147-155.
11. Zhou, Q., T. L. Smith, and F. A. Kummerow. 1993. Cytotoxicity of oxysterols on cultured smooth muscle cells from human umbilical arteries. Proc. Soc. Exp. Biol. Med. 202:75-80.
12. Hodis, H. N , D. W. Crawford, and A. Sevanian. 1991. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel, further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 89:117-126
13. Carew, T. E., D C. Schwenke, and D. Steinberg. 1987. An antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect, evidence that antioxidants in vivo can selectively inhibit low density degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc. Natl. Acad. Sci. USA. 84:7725-7729.
14. Bjorkhem, I., A. Henriksson-Freyschuss, O Bieuer, U Diczfalusy, L. Berglund, and P Henriksson 1991. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11:15-22
15. Freyschuss, A , A. Stiko-Ram, J. Swedenborg, P. Henriksson, I. Björkhem, L. Berglund, and J. Nilsson. 1993 Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J. Clin. Invest 91:1282-1288.
16. Hodis, H. N., A. Chauhan, S. Hashimoto, D. W Crawford, and A. Sevanian. 1992. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effects Atherosclerosis 96:125-134.
17. Mattsson, L., G. Bondjers, and O. Wiklund 1991. Isolation of cell populations from arterial tissue, using monoclonal antibodies and magnetic microspheres Atherosclerosis 89.25-34.
18. Björkhem, I., O. Andersson, U. Diczfalusy, B. Sevastik, R.-J. Xiu, C. Duan, and E Lund 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination ot cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91:8592-8596.
19. Mattsson, L H. Johansson, M. Ottosson, G. Bondjers, and O. Wiklund. 1993. Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J. Clin. Invest. 92:1759-1765.
20. Behr, S. R., and F B. Kraemer. 1986. Effects of activation on lipoprotein lipase secretion by macrophages: evidence for autoregulation. J. Exp Med. 164:1362-1367
21. Ishibashi, S., N. Mori, T. Murase, H. Shimano, T. Gotohda, M. Kawakami, Y. Akanuma, F Takaku, and N. Yamada. 1989. Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins. Arteriosclerosis 9:650-655.
22. Sofer, O., and R. Goldman. 1987. Bacterial lipopolysaccaride suppresses the expression of lipoprotein lipase in murine macrophages: a process independent of tumor necrosis factor or interleukin 1. Immunol. Lett. 15:261-265.
23. Sofer, O., M. Fainaru, Z. Schafer, and R. Goldman. 1992. Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro Arterioscler. Thromb 12 1458-1466.
24. Wiklund, O , L Mattsson, T. Bjornheden, C. Camcjo, and G. Bondjers. 1991. Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: the role of local modification. J. Lipid Res. 32:55-62.
25. Rosenfeld, M. E., J. C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J. L. Witztum 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low density lipoproteins. and contain oxidation-specific lipid-protein adducts. J Clin. Invest. 87:90-99.
26. Bondjers, G., T. Linden, G. Fager, S -O. Olofsson, G. Olsson, and O. Wiklund. 1988 Aortic intimal lipid content and serum lipoproteins in patients undergoing coronary by-pass surgery as related to clinical prognosis. Atherosclerosis. 72.231-239.
27. Folch, J., M Lees, and G. H. A. Sloane-Stanley. 1960. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem 226.497-509
28. Breuer, O., and I. Björkhem. 1990. Simultaneous quantification of several cholesterol autoxidation and monohydroxylation products by isotope-dilution mass spectrometry. Steroids. 55:85-192
29. Kaluzny, M. A., L. A Duncan, M. V. Merritt, and D. E. Epps. 1985. Rapid separation of lipid classes in high yield and purity using bonded phase columns J Lipid Res 26.135-140.
30. Boyum, A. 1976. Isolation of lymphocytes, granulocytes and macrophages. Scand J. Immunol. 5(Suppl. 5):9-15.
31. Bengtsson-Olivecrona, G , and T. Olivecrona 1992. Assay of lipoprotein lipase and hepatic lipase. In Lipoprotein Analyses: A Practical Approach. C. A. Converse and E. R. Skinner, editors. Oxford University Press, Oxford. 169-185.
32. Spooner, P. M , M. M. Garrison, and R. O. Scow 1977. Regulation of mammary and adipose tissue lipoprotein lipase and blood triacylglycerol in rats during late pregnancy. J. Clin. Invest. 60.702-708.
33. Chirgwin, J. M., A. M. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5298.
34. Wion, K L., T. G. Kirchgessner, A. J. Lusis, M. C. Schotz, and R. M Lawn. 1987. Human lipoprotein lipase complementary DNA sequence. Science (Wash. DC). 235:1638-1641.
35. 2+ ions: identification of major products and their effects. Biochem Biophys. Res. Commun. 176: 431-440.
36. Schroepfer, G. J., Jr. 1981 Sterol biosynthesis. Annu. Rev Biochem 50: 585-621
37. Stalenhoef, A. F. H., H. A Kleinveld, T G. Kosmeijer-Schuil, P. N. M. Dermacker, and M. B Katan. 1993. In vivo oxidised cholesterol in atherosclerosis. Atherosclerosis. 98:113-114.
38. Björkhem, I , E. Reihnér, B. Angelin, S Ewerth, J-E. Ǎkerlund, and K. Einarsson. 1987. On the possible use of the serum level of 7α-hydroxycholesterol as a marker for increased activity of the cholesterol 7α-hydroxylase in humans. J Lipid Res 28:889-894.
39. Peng, S., G A. Phillips, G -Z. Xia, and R. J. Morin. 1987. Transport of cholesterol autoxidation products in rabbit lipoproteins. Atherosclerosis. 64:1-6.
40. Peng, S , C. B. Taylor, J C Hill, and R. J. Morin. 1985. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis 54:121-133
41. Baranowski, A., C. W. M. Adams, O. B. Bayliss-High, and D. B. Bowyer. 1982. Connective tissue responses to oxysterols. Atherosclerosis. 41:255-266.
42. Boissonneault, G. A., B. Hennig, and C.-M. Ouyang. 1991. Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer barrier function. Proc. Soc Exp. Biol Med. 196:338-343.
43. Hennig, B., and G A Boissonneault 1987. Cholestane-3β-5α-6β-triol decreases barrier function of cultured endothelial cell monolayers. Atherosclerosis. 68:255-261.
44. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-1266
45. Yla-Herttuala, S , B. A. Lipton, M. E. Rosenfeld, I. J. Goldberg, D. Steinberg, and J. L. Witztum 1991. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl. Acad. Sci. USA. 88:10143-10147.
46. O'Brien, K. D., D. Gordon, S. Deeb, M. Ferguson, and A. Chait. 1992. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 89:1544-1550.
47. O'Brien, K D., S. S Deeb, M Ferguson, T. O. McDonald, M. D. Allen, C. E. Alpers, and A. Chait. 1994. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybrization and immunohistochemistry and comparison with lipoprotein lipase. Am. J. Pathol. 144:538-548.
48. Chisolm, G. M., G. Ma, K. C. Irwin, L. L. Martin, K. M. Gunderson, L. F. Linberg, D. W. Morel, and P. E. DiCorleto. 1994. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91: 11452-11456.
49. Carpenter K. L. H., S. E. Taylor, C. van der Veen, B. K. Williamson, J. B. Ballantine, and M. J. Mitchinson. 1995. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim. Biophys. Acta. 1256:141-150.
50. Ridgway, N. D., P. A. Dawson, Y. K. Ho, M. S. Brown, and J. L. Gold stein 1992. Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. J. Cell Biol. 116:307-319.
51. Goldstein, J. L., and M. S. Brown 1990. Regulation of the mevalonate pathway. Nature (Lond.). 343:425-430.
52. Paik, Y.-K., D. J. Chang, C A. Reardon, M. D. Walker, E Taxman, and J. M. Taylor. 1988. Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J. Biol. Chem. 263:13340-13349.
53. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.